Estados financieros detallados de Mereo BioPharma Group plc (MREO): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $0.27, MREO presenta beneficios negativos (P/E no significativo) y un ROE del -74.76%. La capitalización bursátil es de $42M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | -$3.3M | 0 | 0 | 0 | $49.2M | 0 | $10.0M | 0 | $500000 |
| Coste de Ventas | $24.6M | $34.6M | $22.7M | $2.0M | $2.1M | $24.2M | -$1.1M | $2.6M | 0 | $133000 |
| Beneficio Bruto | -$24.6M | -$37.9M | -$22.7M | -$2.0M | -$2.1M | $25.0M | $1.1M | $7.4M | 0 | $367000 |
| I+D | $24.6M | $34.6M | $22.7M | $30.1M | $21.0M | $31.8M | $29.5M | $17.4M | 0 | $17.8M |
| Generales y Administrativos | $11.6M | $10.7M | $12.5M | $18.3M | $25.2M | $21.5M | $26.1M | $18.4M | 0 | $23.0M |
| Gastos Operativos | $11.6M | $10.7M | $12.5M | $48.4M | $46.1M | $53.3M | $55.6M | $35.8M | 0 | $38.6M |
| Beneficio Operativo | -$36.2M | -$45.3M | -$35.2M | -$50.4M | -$48.2M | -$28.3M | -$54.4M | -$28.4M | 0 | -$38.3M |
| EBITDA | -$38.4M | -$44.4M | -$34.9M | -$44.6M | -$203.4M | $25.5M | -$37.9M | -$26.1M | 0 | -$40.5M |
| Gastos por Intereses | $179765 | $1.1M | $2.4M | $3.5M | $6.4M | $5.2M | $4.2M | $2.9M | 0 | $255000 |
| Beneficio Antes de Impuestos | -$33.7M | -$47.0M | -$37.3M | -$52.5M | -$213.4M | $19.2M | -$42.9M | -$30.0M | 0 | -$41.9M |
| Impuestos | -$5.3M | -$8.2M | -$5.3M | -$8.0M | -$3.6M | $2.0M | -$718000 | -$532000 | 0 | 0 |
| Beneficio Neto | -$28.4M | -$38.8M | -$32.0M | -$44.5M | -$209.8M | $17.2M | -$42.2M | -$29.5M | 0 | -$41.9M |
| BPA | $-19553.91 | $-19003.80 | $-14352.87 | $-12902.58 | $-16503.30 | $749.65 | $-1.80 | $-1100.22 | $0.00 | $-0.26 |
| BPA Diluido | $-19553.91 | $-19003.80 | $-14352.87 | $-12902.58 | $-16503.30 | $749.65 | $-1.80 | $-1100.22 | $0.00 | $-0.26 |
| Acciones en Circulación (Diluidas) | $9.0M | $13.8M | $14.2M | $17.9M | $67.8M | $116.7M | $22.8M | $131.9M | 0 | $159.4M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $53.6M | $50.0M | $25.0M | $20.9M | $31.3M | $126.7M | $68.2M | $57.4M | $69.8M | $41.0M |
| Inversiones a Corto | 0 | $2.5M | $2.5M | $720634 | $748034 | $769470 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $995784 | $509350 | 0 | 0 | 0 | 0 | $3.2M | $3.7M | $3.2M | $2.0M |
| Inventario | -$53.9M | -$2.5M | -$293328 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $60.8M | $63.2M | $34.5M | $40.3M | $40.7M | $134.3M | $75.2M | $63.8M | $74.8M | $45.0M |
| Inmovilizado Material | $173869 | $153361 | $148935 | $15.3M | $2.2M | $3.4M | $2.2M | $1.6M | $984000 | $381000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $25.8M | $33.0M | $32.6M | $58.9M | $43.3M | $33.2M | $29.0M | $1.1M | $643000 | $516000 |
| Activos Totales | $86.8M | $96.3M | $67.3M | $114.5M | $86.1M | $171.0M | $77.4M | $66.5M | $76.4M | $45.9M |
| Cuentas por Pagar | $1.2M | $2.6M | $5.6M | $8.1M | $4.3M | $3.1M | $3.5M | $2.3M | $2.4M | $1.3M |
| Deuda a Corto | 0 | $1.9M | $6.8M | $20.1M | 0 | 0 | $13.3M | 0 | $5.5M | 0 |
| Pasivos Corrientes | $3.2M | $9.6M | $16.2M | $39.6M | $11.7M | $17.0M | $24.4M | $9.5M | $13.8M | $4.3M |
| Deuda a Largo | $3.1M | $18.8M | $14.6M | $7.1M | $22.1M | $19.5M | 0 | $4.4M | 0 | 0 |
| Pasivos Totales | $7.5M | $33.9M | $34.5M | $61.2M | $106.6M | $51.9M | $26.0M | $16.0M | $15.4M | $5.0M |
| Reservas | -$33.6M | -$79.3M | -$111.2M | -$193.5M | -$423.5M | -$401.6M | -$404.6M | -$419.6M | -$462.9M | -$501.0M |
| Patrimonio Neto | $79.3M | $62.5M | $32.8M | $53.3M | -$20.5M | $119.0M | $51.4M | $50.5M | $61.0M | $40.9M |
| Deuda Total | $3.1M | $20.8M | $21.5M | $42.9M | $24.5M | $22.7M | $15.4M | $6.0M | $6.4M | $202000 |
| Deuda Neta | -$50.5M | -$31.8M | -$6.1M | $21.3M | -$7.6M | -$104.9M | -$52.8M | -$51.5M | -$63.4M | -$40.8M |
| Capital Circulante | $57.6M | $53.6M | $18.3M | $737856 | $28.9M | $117.4M | $50.8M | $54.3M | $60.9M | $40.7M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$33.7M | -$47.0M | -$37.3M | -$53.9M | -$226.8M | $19.2M | -$42.2M | -$29.5M | -$43.3M | -$41.9M |
| Amortizaciones | $32940 | $36076 | $37796 | $2.1M | $2.2M | $866466 | $889000 | $1.1M | $1.1M | $622000 |
| Compensación en Acciones | $6.5M | $3.7M | $2.2M | $2.1M | $2.1M | $4.5M | $4.8M | $4.9M | $7.4M | $7.6M |
| Cambio en Capital Circulante | -$2.0M | $3.0M | $2.4M | -$10.1M | -$4.6M | -$2.5M | -$2.4M | -$1.6M | -$369000 | -$3.2M |
| Flujo de Caja Operativo | -$27.4M | -$32.1M | -$23.1M | -$60.2M | -$38.6M | -$7.1M | -$48.8M | -$21.1M | -$32.8M | -$31.0M |
| Inversiones (CapEx) | -$3467 | -$2.3M | -$35536 | -$27534 | -$21805 | -$722055 | -$13000 | -$419000 | -$699000 | -$20000 |
| Adquisiciones | 0 | 0 | 0 | $13.2M | -$482440 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$306838 | -$1.3M | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$27.4M | -$34.4M | -$23.2M | -$60.3M | -$38.6M | -$7.8M | -$48.8M | -$21.6M | -$33.5M | -$31.0M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +100.0% | -100.0% | -100.0% | |||||||
| Crecimiento Beneficio Neto (anual) | -36.7% | +17.4% | -38.8% | -372.0% | +108.2% | -345.8% | +30.2% | +100.0% | ||
| Crecimiento BPA (anual) | +2.8% | +24.5% | +10.1% | -27.9% | +104.5% | -100.2% | -61023.3% | +100.0% | ||
| Cambio en Acciones (anual) | +54.1% | +3.1% | +25.7% | +279.0% | +72.2% | -80.5% | +478.5% | -100.0% | ||
| Crecimiento FCF (anual) | -25.7% | +32.7% | -160.0% | +35.9% | +79.8% | -526.7% | +55.9% | -55.6% | +7.6% | |
| Margen Bruto | 1153.4% | 50.9% | 74.3% | 73.4% | ||||||
| Margen Operativo | 1379.0% | -57.4% | -284.2% | -7651.4% | ||||||
| Margen EBITDA | 1352.7% | 51.8% | -260.6% | -8094.8% | ||||||
| Margen Neto | 1181.0% | 34.9% | -294.7% | -8375.6% | ||||||
| Margen FCF | 1048.4% | -15.8% | -215.5% | -6198.2% | ||||||
| Tasa Impositiva Efectiva | 15.8% | 17.4% | 14.1% | 15.3% | 1.7% | 10.6% | 1.7% | 1.8% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-3.06 | $-2.50 | $-1.63 | $-3.37 | $-0.57 | $-0.07 | $-2.14 | $-0.16 | $-0.19 | |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Acciones en Circulación (Básicas) | $9.0M | $13.8M | $14.2M | $17.9M | $67.8M | $116.7M | $22.8M | $131.9M | 0 | $159.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -74.76% |
| Rentabilidad sobre capital invertido | -111.41% |
| Rentabilidad sobre activos | -80.88% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.04 |
| Ratio corriente | 5.88 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -8.98 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.42 | -0.00 | 0.00 | -1.60 |
| P/VC | 0.73 | 1.44 | 2.82 | 1.10 | -11.85 | 1.57 | 0.33 | 6.03 | 0.00 | 1.62 |
| P/V | 0.00 | -27.31 | 0.00 | 0.00 | 0.00 | 3.80 | 0.00 | 30.47 | 0.00 | 132.86 |
| Margen Bruto | 0.0% | 1153.4% | 0.0% | 0.0% | 0.0% | 50.9% | 0.0% | 74.3% | 0.0% | 73.4% |
| Margen Operativo | 0.0% | 1379.0% | 0.0% | 0.0% | 0.0% | -57.4% | 0.0% | -284.2% | 0.0% | -7651.4% |
| Margen Neto | 0.0% | 1181.0% | 0.0% | 0.0% | 0.0% | 34.9% | 0.0% | -294.7% | 0.0% | -8375.6% |
Empresas relacionadas: ACIU · ALDX · CADL · CAPR · CTNM · IMMP · KYTX
Explorar sector: Healthcare · Biotechnology
Más secciones de MREO: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones